HER2 Support Group Forums - View Single Post - Positive results from Genentech's pertuzumab plus Herceptin Phase III study on HER2-p

News · 12-08-2011, 12:13 AM

Genentech, a member of the Roche Group, today announced results from CLEOPATRA, the first randomized Phase III study of the investigational HER2-targeted medicine pertuzumab.

More...

12-08-2011, 12:13 AM	#1
News Senior Member Join Date: Oct 2007 Posts: 19,720	Positive results from Genentech's pertuzumab plus Herceptin Phase III study on HER2-p Genentech, a member of the Roche Group, today announced results from CLEOPATRA, the first randomized Phase III study of the investigational HER2-targeted medicine pertuzumab. More...